Suchergebnisse - "Georgiev, Pencho"

PubPharm (14)

1

Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

enthalten in: Leukemia | 2023

von Gisslinger, H. | Klade, C. | Georgiev, P. | +17

2

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

enthalten in: Leukemia | 2022

von Kiladjian, J. | Klade, C. | Georgiev, P. | +27

3

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Pasi, K. | Lissitchkov, T. | Mamonov, V. | +12

4

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

enthalten in: Journal of Thrombosis and Haemostasis | 2021

von Pasi, K. | Lissitchkov, T. | Mamonov, V. | +12

5

Ropeginterferon Alfa-2b : Efficacy and Safety in Different Age Groups

enthalten in: HemaSphere | 2020

von Gisslinger, H. | Klade, C. | Georgiev, P. | +14

6

Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities

enthalten in: Folia medica | 2020

von Georgiev, P. | Sapunarova, K. | Goranova-Marinova, V. | +1

7

Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta-thalassaemia

enthalten in: Annals of medicine | 2020

von Sapunarova, K. | Goranova-Marinova, V. | Georgiev, P. | +3

8

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV) : a randomised, non-inferiority, phase 3 trial and its extension study

enthalten in: The Lancet. Haematology | 2020

von Gisslinger, H. | Klade, C. | Georgiev, P. | +59

ErratumIn: Lancet Haematol. 2020 Feb 25;:. - PMID 32109379

9

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

enthalten in: The New England journal of medicine | 2020

von Cappellini, M. | Viprakasit, V. | Taher, A. | +138

10

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation : a phase 3, randomized, multicentre trial (PIX306)

enthalten in: British journal of haematology | 2020

von Pettengell, R. | Długosz-Danecka, M. | Andorsky, D. | +8

CommentIn: Br J Haematol. 2020 Jan;188(2):202-204. - PMID 31680237